Ouro Medicines

Developer of therapeutics for people living with chronic immune-mediated diseases

placeSan Francisco, California, United States calendar_todayFounded 2024 language ouromedicines.com

Social engagement

Social engagement: 3.3K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include TPG, New Enterprise Associates.

Investor typeCountShare
Venture capital450%
Private equity225%
Other / undisclosed225%

Recent activity

17 Dec 2025
Event
44th Annual J.P. Morgan Healthcare Conference
4 Dec 2025
Event
American Society of Hematology (ASH) Annual Meeting
9 Oct 2025
Partnership
THREAD
Coming soon